Related Experiment Video
Updated: Nov 15, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.2K
Treating acute severe asthma attacks in children: using aminophylline.
A Aralihond1,2, Z Shanta1, A Pullattayil1
1Sidra Medicine, Doha, Qatar.
Breathe (Sheffield, England)
|March 5, 2021
Summary
Aminophylline can treat severe asthma attacks in children. Careful management is crucial due to potential toxic side effects, requiring clinician awareness for safe and effective use in pediatric asthma patients.
Area of Science:
- Pediatric Pulmonology
- Clinical Pharmacology
Background:
- Severe asthma attacks in children pose significant clinical challenges.
- Aminophylline, a theophylline derivative, is considered for refractory cases.
Discussion:
- Aminophylline's efficacy in severe pediatric asthma necessitates careful risk-benefit assessment.
- Clinicians must be vigilant for potential toxic side effects, including seizures and arrhythmias.
- Therapeutic drug monitoring is essential to maintain efficacy and minimize toxicity.
Key Insights:
- Aminophylline demonstrates a therapeutic role in managing severe asthma exacerbations in pediatric populations.
- Awareness and proactive management of aminophylline's adverse effects are paramount for patient safety.
- Individualized dosing and close monitoring are critical for optimizing aminophylline therapy in children.
Outlook:
- Further research into safer administration protocols for aminophylline in children is warranted.
- Exploring alternative bronchodilators with improved safety profiles remains an ongoing objective.
- Enhanced clinical guidelines for aminophylline use in pediatric severe asthma are needed.
Related Concept Videos
01:24Antiasthma Drugs: Methylxanthines
1.4K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.4K
01:30Adrenergic Agonists: Therapeutic Uses
1.4K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.4K
01:30Asthma-IV: Diagnostic and Management
2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.4K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.4K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.5K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.5K